Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients
Franziska Blaeschke, Semjon Willier, Dana Stenger, Mareike Lepenies, Martin A. Horstmann, Gabriele Escherich, Martin Zimmermann, Francisca Rojas Ringeling, Stefan Canzar, Theresa Kaeuferle, Meino Rohlfs, Vera Binder, Christoph Klein, Tobias Feuchtinger
Topics & Concepts
Bone marrowCD8LeukemiaT cellMedicineImmunologyImmune systemCytotoxic T cellMinimal residual diseaseCancer researchInternal medicineOncologyBiologyIn vitroBiochemistryCAR-T cell therapy researchImmune Cell Function and InteractionGalectins and Cancer Biology